產(chǎn)品名稱(chēng) |
FW11-9-2 |
商品貨號(hào) |
B164474 |
Organism |
Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
Cell Type |
hybridoma: B lymphocyte |
Product Format |
frozen |
Morphology |
lymphoblast |
Culture Properties |
suspension |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Applications |
Animals were immunized with a fusion protein corresponding to the variant region of human CD44 (exons 3v to 10v). The antibody is specific for the product of the 6v exon. |
Derivation |
Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
Genes Expressed |
immunoglobulin; monoclonal antibody; against the v6 variant of human CD44 |
Cellular Products |
immunoglobulin; monoclonal antibody; against the v6 variant of human CD44 |
Comments |
Animals were immunized with a fusion protein corresponding to the variant region of human CD44 (exons 3v to 10v). Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody is specific for the product of the 6v exon. |
Complete Growth Medium |
Iscove's modified Dulbecco's medium with 2 mM L-glutamine, 90%; fetal bovine serum, 10%
|
Subculturing |
Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
Cryopreservation |
Culture medium, 95%; DMSO, 5% |
Isotype |
IgG2a |
Name of Depositor |
CR Mackay |
Deposited As |
mouse (B cell); mouse (myeloma) |
References |
Mackay CR, et al. Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol. 124: 71-82, 1994. PubMed: 7507492
|